![Stephen Dilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Dilly
Chairman at
CODEXIS, INC.
Net worth: 1 M $ as of 2026-07-30
Profile
Stephen George Dilly is President, Chief Executive Officer & Director at Sonoma Biotherapeutics, Inc. since 2025.
Executive Chairman at Codexis, Inc. since 2025.
Director at Adjuvance Technologies, Inc. and Director at Aurimi Therapeutics, Inc. since 2020.
Formerly President, Chief Executive Officer & Director at Sierra Oncology, Inc. from 2020 to 2022; President, Chief Executive Officer & Director at Aimmune Therapeutics, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at PhotoThera, Inc. from 2011 to 2012; President, Chief Executive Officer & Director at APT Pharmaceuticals, Inc. from 2006 to 2011; Executive Chairman at DNAtrix, Inc.; Chairman at Cognoa, Inc.; Director at Avigen, Inc. from 2007 to 2009; Independent Director at Sangamo Therapeutics, Inc. from 2010 to 2020; Vice President-Development Sciences at Genentech, Inc. from 2002 to 2003; Advisor at Physic Ventures LLC; Chief Medical Officer & SVP-Development at CHIRON Biopharmaceuticals from 2003 to 2006.
Education includes two doctorates from the University of London, conferred in 1982 and 1988.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CODEXIS, INC. 0.68% | 2026-06-16 | 727,053 ( 0.68% ) | 1 M $ | 2026-07-30 |
Stephen Dilly active positions
| Companies | Position | Start |
|---|---|---|
| CODEXIS, INC. | Chairman | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Director/Board Member | 2020-02-06 |
Adjuvance Technologies, Inc.
 Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Director/Board Member | - |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Chief Executive Officer | 2025-11-16 |
Former positions of Stephen Dilly
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Chief Executive Officer | 2022-06-30 |
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 2020-09-29 |
| AIMMUNE THERAPEUTICS, INC. | Chief Executive Officer | 2018-06-18 |
PhotoThera, Inc.
 PhotoThera, Inc. Medical SpecialtiesHealth Technology Develops and distributes infrared therapeutic devices | Chief Executive Officer | 2012-11-30 |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Chief Executive Officer | 2011-11-30 |
Training of Stephen Dilly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
PhotoThera, Inc.
PhotoThera, Inc. Medical SpecialtiesHealth Technology Develops and distributes infrared therapeutic devices | Health Technology |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physic Ventures LLC
 Physic Ventures LLC Investment ManagersFinance Physic Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
CHIRON Biopharmaceuticals | |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Health Services |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
- Stock Market
- Insiders
- Stephen Dilly
